Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-03187207 vs Latanoprost in Glaucoma and Ocular Hypertension
NCT00441883Phase 2Completed
- Sponsor
- Bausch + Lomb
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of latanoprostene bunod in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Bausch + Lomb. Started Mar 2007; status: completed.
02
Drugs
latanoprostene bunod
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT00441883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441883.